tbuckley/cabot-search huggingface dataset:
SAT-438 Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Authors: Zobair Younossi, Yusuf Yilmaz, Ming-Lung Yu, Vasily Isakov, Marlen Ivon Castellanos Fernández, Vincent Wai-Sun Wong, Yuichiro Eguchi, Manuel Romero-Gómez, Nahum Méndez-Sánchez, Ajay Kumar Duseja, Caglayan Keklikkiran, Jacob George, Elisabetta Bugianesi, Ashwani K. Singal, Saeed Sadiq Hamid, Khalid A. Alswat, Wah-Kheong Chan, Jiangao Fan, George Papatheodoridis, Stuart C. Gordon, Mohamed El-Kassas, Stuart Roberts, Brian Lam, Andrei Racila, Linda Henry, Saleh Alqahtani, Maria Stepanova
Journal: Journal of Hepatology (2024)
THU-413 Baseline gamma-glutamyl transpeptidase levels are associated with aggravation of esophagogastric varix after direct-acting antiviral therapy in cirrhotic patients with hepatitis C virus
Authors: Yuki Tahata, Hayato Hikita, Satoshi Mochida, Akio Ido, Daiki Miki, Ryotaro Sakamori, Hitoshi Yoshiji, Norifumi Kawada, Nobuyuki Enomoto, Taro Yamashita, Masayuki Kurosaki, Hidekatsu Kuroda, Yoichi Hiasa, Kazuhiko Nakao, Naoya Kato, Goki Suda, Yasunari Nakamoto, Hiroshi Yatsuhashi, Kentaro Matsuura, Taro Takami, Eiji Kakazu, Yoshito Itoh, Yasuhiro Asahina, Yoshiyuki Ueno, Ryosuke Tateishi, Shuji Terai, Masahito Shimizu, Norio Akuta, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara
Journal: Journal of Hepatology (2024)
WED-246 A non-invasive index for significant liver fibrosis and stratifying risk of cirrhosis in patients with type 2 diabetes mellitus in primary care
Authors: Xiaolong Qi, Dongfang You, Jie Shen, Chuan Liu, Yuping Chen, Ming-Hua Zheng, Xiqiao Zhou, Mingxing Huang, Xuan Liang, Tianxurun Deng, Chao Sun, Xiao Liang, Yong-Fen Zhu, Fangfang Lv, Heng Wan, Fenxiang Li, Dengxiang Liu, Yan Wang, Tang Dong, Xiaoxiong Hu, Baiyun Li, Yuting Zhang, Rong Zhang, Jing Du, Yanan Han, Fang Li, Xuanzhe Zhang, Wen-Yue Liu, Yusen Zhou, Xinjie Li, Youfang Gao, Lan Ma, Wenhua Zhang, Fengmei Wang, Jinfen Wei, Chengyu Liu, Xing Liu, Shanghao Liu, Xiaomei Wang, Jing Wang, Xianmei Meng, Jing Hu, Jinpeng Hu, Jiaojian Lv, Chuxiao Shao, Ruiling He, Taolong Zhou, Yijun Tang, Xuefeng Li, Min Li, Junwei Cai, Yuwei Zhang, Liu Wang, Qing Shao, Yuehua Wang, An Zhou, Xiaoming Wu, Wenjing Ni, Jie Li, Ling Li, Zhihui Li, Wannian Liang, Weimin Jiang, Yang Zhao, Lixin Guo, Vincent Wai-Sun Wong, Gao-Jun Teng
Journal: Journal of Hepatology (2024)
THU-236-YI Oxysterol treatment causes indirect stellate cell activation: a potential mechanism linking steroid metabolising enzyme dysregulation with fibrosis
Authors: Hamish Miller, Patricia Garrido, Wenhao Li, Raju Kumar, Iris Gines, Nikolaos Nikolaou, Tom Potter, Maíra Bailey, Fredrik Karpe, Matthew Neville, Márta Korbonits, William Griffiths, Yuqin Wang, William Alazawi, Jeremy Tomlinson
Journal: Journal of Hepatology (2024)
THU-406 Knowledge, perceptions and barriers to the diagnosis and treatment of hepatitis C among persons who inject drugs: findings from the Educate-Test-Treat (ETT) programme in Singapore
Authors: Alyssa Sim, Shann Long, Sanchalika Acharyya, Gerard Wong, Ryan Jia Jie Liew, Kuo Chao Yew
Journal: Journal of Hepatology (2024)
THU-222-YI The exercise-induced metabokine beta-aminoisobutyric acid regulates hepatic lipid metabolism and reduces hepatic metabolic dysfunction and fatty liver in a dietary obese mouse model
Authors: Shaimaa Gad, Helene Daou, Amanda MacCannell, Nicole Watt, Laeticia Lichtenstein, David Beech, Scott Bowen, Lee Roberts
Journal: Journal of Hepatology (2024)
WED-282 Prevalence of LowFibrosis-4 Score in Patients with MASLD-related Hepatocellular Carcinoma: Results from a Multicentre Cohort Study
Authors: Benedix Sim, Nobuharu Tamaki, Beom Kyung Kim, Karn Wijarnpreecha, Darren Jun Hao Tan, Majd Aboona, Claire Faulkner, Ken Liu, Wen Hui Lim, Nicholas Syn, Cheng Han Ng, Daniel Tung, Benjamin Tay, Yi Qing Tey, John Mok, Benjamin Nah, Maureen da Costa, Shridhar Iyer, Glenn Bonney, Alfred Kow, Mark Muthiah, Margaret Teng, Anand KulkarnI, Sung Won Lee, Rohit Loomba, Daniel Huang
Journal: Journal of Hepatology (2024)
THU-405 Analysis of a decentralized model interdisciplinary for the elimination of HCV in vulnerable population in the province of Huelva (Spain). To continue advancing in the elimination of hepatitis C, it is necessary to establish a clearly defined integrated care plan
Authors: Gema Romero, Ana Bejarano, Francisco Franco, Pilar Del Pino, Maria Dolores Santos
Journal: Journal of Hepatology (2024)
THU-304 Performance of non-invasive indexes in the assessment of metabolic dysfunction-associated steatotic liver disease
Authors: Álvaro Yagüe Parada, Andrés Felipe Castañeda Agredo, Rocio Calvo Hernandez, Agustina Gonzalez Guirado, Andres Varela Silva, Marta Morán Ortiz de Solorzano, Michelle Casanova Cabral, Benjamin Polo Lorduy
Journal: Journal of Hepatology (2024)
WED-207 Non-invasive biomarkers of liver fibrosis may be used for diagnosing fibrosis and prognostication in patients with metabolic dysfunction-associated steatotic liver disease
Authors: Liv Eline Hetland, Mikkel Werge, Mira Thing, Elias Rashu, Puria Nabilou, Nina Kimer, Anders Junker, Diana Leeming, Morten Karsdal, Alejandro Mayorca Guiliani, Lise Lotte Gluud
Journal: Journal of Hepatology (2024)
WED-177 Determination of liver biopsy quality criteria for the diagnosis of porto-sinusoidal vascular disorder (PSVD)
Authors: Chloé De Broucker, Valérie Paradis, Miguel Albuquerque, Audrey Payancé, Aurélie Plessier, Francois Durand, Paul Emile Zafar, Pierre-Emmanuel Rautou
Journal: Journal of Hepatology (2024)
SAT-373 Intrahepatic sodium taurocholate co-transporting polypeptide gene transcript and membrane-localized protein expression changes in chronic hepatitis D patients following 48 weeks of treatment with Bulevirtide
Authors: Wildaliz Nieves, David Pan, Abhishek Aggarwal, Shiva Zaboli, Christina Moon, Lauri Diehl, Liyun Ni, Savrina Manhas, Hongmei Mo, Lena Allweiss, Dmitry Manuilov, Grace M. Chee, Renee-Claude Mercier, Jeffrey Wallin, Maura Dandri-Petersen
Journal: Journal of Hepatology (2024)
FRI-398 Targeted capture single-cell sequencing provides new insights into persistent hepatitis B virus (HBV) infection
Authors: Yanfang Huang, Hongyuan Xue, Yongping Liu, Miaoqu Zhang, Qiran Zhang, Jinhang He, Ning Jiang, QuanBao Zhang, Zhengxin Wang, Chao Qiu, Wenhong Zhang
Journal: Journal of Hepatology (2024)
SAT-375 Proteomic analysis of plasma exosomes: a novel method to identify potential therapeutic targets for chronic hepatitis B
Authors: Meng Zhao, Saisai Zhang, Danny Ka-Ho Wong, Lung-Yi Mak, Judy Wai-Ping Yam, Cherlie Lot-Sum Yeung, Rex Wan-Hin Hui, Man-Fung Yuen, Wai-Kay Seto
Journal: Journal of Hepatology (2024)
SAT-420 The Chinese herbal TiaoGanJianPiJieDu formula exerts an inhibition effect on hepatitis B virus replication by regulating hepatic CCL2-CCR2 signaling pathway and inducing immuneinflammatory response
Authors: Ningyi Zhang, Hening Chen, Xu Cao, Xiaobin Zao, Yong'an Ye
Journal: Journal of Hepatology (2024)
SAT-341 Discovery of a pan-genotypic hepatitis E virus replication inhibitor
Authors: Xin Zhang, Mara Klöhn, Sivi Ouwerkerk-Mahadevan, Michelle Jagst, Liesbeth Vereyken, Peter Verboven, Daniel Todt, Tim H.M. Jonckers, Lotte Coelmont, Helen Fletcher, Kirandeep Samby, Anil Koul, Johan Neyts, Eike Steinmann, Suzanne J.F. Kaptein
Journal: Journal of Hepatology (2024)
SAT-407 Long-term sustained decline of anti-HCV neutralizing antibodies in HIV/HCV-coinfected patients after therapy-induced HCV clearance
Authors: Daniel Sepúlveda-Crespo, Camilla Volpi, Rafael Amigot-Sánchez, Marta Quero-Delgado, María Yélamos, Cristina Diez, Julián Gómez, Victor Hontañón, Juan Berenguer, Juan Gonzalez, Rubén Martín-Escolano, Salvador Resino Garcia, Isidoro Martínez
Journal: Journal of Hepatology (2024)
WED-152 Design and study population of MITIGATE: the first multinational randomized controlled clinical trial in IgG4 related disease, evaluating the efficacy and safety of the CD19 B cell depleting agent inebilizumab
Authors: John Stone, Emma Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Lohr, Nicolas Schleinitz, Lingli Dong, Hisanori Umehara, Marco Lanzillotta, Zachary Wallace, Mikael Ebbo, George Webster, Yanping Wu, Daniel Cimbora, Nishi Rampal
Journal: Journal of Hepatology (2024)
TOP-360-YI Hepatitis B Spliced-generated Protein (HBSP): a key factor of viral escape
Authors: Pierre Bablon, Hoan Nguyen Dang, Céline Goy, Jules Sotty, Aurélie Schnuriger, Lynda Aoudjehane, Jeremy Augustin, Chiara Guerrera, Valérie Soulard, Jonathan Pol, Camille Sureau, Patrick Soussan
Journal: Journal of Hepatology (2024)
WED-158-YI Disease experience and care expectations in european patients with immune-mediated liver disease
Authors: Pierre-Antoine Soret, Bert Tomsin, José A. Willemse, Martine Walmsley, Victorio Gnutti, Wiebke Papenthin, Natalie Uhlenbusch, Tom J.G. Gevers, Nora Cazzagon, Christoph Schramm, Pierre Corret, Sara Lemoinne, Angela Leburgue
Journal: Journal of Hepatology (2024)
WED-429 Hepatitis B virus care cascade in Rwanda: a population basedstudy
Authors: Jean Damascene Makuza, Dahn Jeong, Marie Paul Nisingizwe, Phymar Soe, Richard Morrow, Georgine Cua, Héctor Alexander Velásquez García, Albert Tuyishime, Michael Law, Alnoor Ramji, Naveed Janjua
Journal: Journal of Hepatology (2024)
THU-367-YI Effectiveness and safety of direct-acting antivirals in the treatment of elderly people infected with HCV
Authors: Michał Brzdęk, Dorota Zarębska-Michaluk, Krzysztof Tomasiewicz, Magdalena Tudrujek-Zdunek, Beata Lorenc, Włodzimierz Mazur, Hanna Berak, Justyna Janocha-Litwin, Jakub Klapaczynski, Ewa Janczewska, Dorota Dybowska, Anna Parfieniuk-Kowerda, Piekarska Anna, Jerzy Jaroszewicz, Robert Flisiak
Journal: Journal of Hepatology (2024)
WED-376 Tobevibart (VIR-3434), a monoclonal antibody, resistance analysis in participants with chronic HBV: Results from a Phase 1 single dose study
Authors: Hasan Imam, Julia di Iulio, Thanh Quach, Yi-Pei Chen, Sonia Maciejewski, Keith Boundy, Andre Arizpe, Kosh Agarwal, Man-Fung Yuen, Andrea Cathcart, Gregory Camus
Journal: Journal of Hepatology (2024)
SAT-449 Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB 4 scores and liver risk score (Cerbafib)
Authors: Henri Tran, Patrick Ingiliz, Vincent Leroy, Stefano Caruso, Anne Laure Mazialivou, Adrien Ko, Odile Rousselet, Cecile Fargeat
Journal: Journal of Hepatology (2024)
SAT-396 Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients
Authors: Lucile Dumolard, Marie-Noëlle Hilleret, Gerster Théophile, Charlotte Costentin, Thomas Decaens, Evelyne Jouvin-Marche, Patrice N Marche, Zuzana Macek Jilkova
Journal: Journal of Hepatology (2024)
WED-395 Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta
Authors: Fabien Zoulim, Tarik Asselah, Vladimir Chulanov, Adrian Streinu-Cercel, George Sebastian Gherlan, Pavel Bogomolov, Tatyana Stepanova, Viacheslav Morozov, Olga Sagalova, Renee-Claude Mercier, Lei Ye, Dmitry Manuilov, Audrey H. Lau, Grace M. Chee, Ben L. Da, Marc Bourliere, Heiner Wedemeyer, Pietro Lampertico
Journal: Journal of Hepatology (2024)
THU-420 Evaluation of LiverRisk score as predictor of liver fibrosis and mortality in patients with HCV-related hepatitis treated with direct acting antivirals
Authors: Antonietta Romano, Amalia Rita Caspanello, Salvatore Piano, Marta Tonon, Carmine Gambino, Valeria Calvino, Anna Barone, Nicola Zeni, Simone Incicco, Roberta Gagliardi, Paolo Angeli
Journal: Journal of Hepatology (2024)
THU-194 Semaglutide links with improved survival and liver outcomes in MASLD patients, a large multicenter retrospective real-world cohort study
Authors: Mohammed Suki, Yael Milgrom, Mohamad Masarowah, Wadiaa Hazo, Yariv Tiram, Ofer Perzon, Esther Forkosh, Joseph Sackran, Johnny Amer, Achraf Imam, Abed Khakayla, Rifaat Safadi
Journal: Journal of Hepatology (2024)
TOP-193 Consumption of a mediterranean diet with high-polyphenol content extra-virgin olive oil (EVOO) in patients with MASLD: effects on clinical parameters and gene expression on peripheral blood mononuclear cells (PBMCs)
Authors: Aurelio Seidita, Alessandra Cusimano, Roberto Citarrella, Antonina Azzolina, Roberta Chianetta, Ida Muratori, Rosalia Caldarella, Antonino Terranova, Anna Licata, Antonio Carroccio, Juan Iovanna, Melchiorre Cervello, Maurizio Soresi, Lydia Giannitrapani
Journal: Journal of Hepatology (2024)
WED-377 Preclinical profiling of ABI-6250, a novel orally bioavailable smallmolecule therapeutic candidate for the treatment of chronic hepatitis D
Authors: Marc P. Windisch, Nuruddin Unchwaniwala, Jinghu Carl Li, Yanhong Zhu, Heidi Contreras, Dinara Azimova, Francielle Tramontini Gomes de Sousa, Joseph Tan, Kirsten Stray, Ariel Tang, Peter Haggie, Gene Schulze, Michael Shen, Jiaxin Yu, Michel Perron, Michael A. Walker, William E. Delaney, Min Zhong
Journal: Journal of Hepatology (2024)
WED-219 Pemvidutide, a glucagon-like peptide 1/glucagon dual receptor agonist, improves metabolic dysfunction-associated steatohepatitis activity and fibrosis in a clinical quantitative systems pharmacology model
Authors: Stephen A. Harrison, John Suschak, Matthew McDaniel, Zackary Kenz, Shaheen Tomah, Jonathan Kasper, M. Scot Roberts, Scott Siler, M. Scott Harris, Sarah Browne
Journal: Journal of Hepatology (2024)
WED-224 Screening for liver fibrosis in tertiary care using automatic calculation of FIB4 in patients at-risk of diabetes
Authors: Clémence M Canivet, Celine Rolland, Francoise Joubaud, Franck Genevieve, Stéphane Gervais, Frédéric Oberti, Delphine Prunier, Valérie Moal, Sophie Michalak, Isabelle Fouchard, Adrien Lannes, Jerome Boursier
Journal: Journal of Hepatology (2024)
THU-382 Lead-in cohort results from a phase 2 study of a novel 8-week combination regimen of Bemnifosbuvir and Ruzasvir in patients with chronic hepatitis C virus infection
Authors: Alina Jucov, Brian Conway, Laura Iliescu, Paul Mitrut, Simin Florescu, Roxana Cernat, Elena Ermacicova, Shannan Lynch, Marina Majarian, Sergey Izmailyan, Xiao-Jian Zhou, Keith Pietropaolo, Bruce Belanger, Arantxa Horga, Janet Hammond
Journal: Journal of Hepatology (2024)
WED-398 HBsAg loss in inactive chronic hepatitis B carriers is dependent on level of qHBsAg and interferon response: a randomised control trial
Authors: Seng Gee Lim, Guan Huei Lee, Yock Young Dan, Yin Mei Lee, Htet Htet Toe Wai Khine, Yuh Ling Amy Tay, Cindy Seah, Liang Shen, None Edwin, Shih-Yen Chan, Martin Hibberd
Journal: Journal of Hepatology (2024)
THU-370 Hepatocellular carcinoma may be a viral reservoir during treatment of hepatitis C with direct-acting antivirals
Authors: Mário Jorge Silva, Ana Patricia Negrinho, Fatima Oliveira Martins, Antonio Figueiredo, Helena Gloria, Carina Santos, Pedro Lages Martins, Vasco Ribeiro, Mario Oliveira, Hugo Pinto Marques, Silvia Vilares Conde, Filipe Calinas
Journal: Journal of Hepatology (2024)
WED-268 Natural history and expected change over time for MRI derived cT1: Data from clinical trials and the UK Biobank
Authors: Charlie Diamond, Cayden Beyer, Elizabeth Shumbayawonda, John McGonigle, Tim Rolph, Kitty Yale, Rajarshi Banerjee, Helena Thomaides Brears, Andrea Dennis, Michele Pansini, Naim Alkhouri
Journal: Journal of Hepatology (2024)
THU-239-YI Metabolic dysfunction-associated steatotic liver disease (MASLD) modeling with hepatocyte-like cells derived from adult liver stem cells via air-liquid interface
Authors: Soe Einsi Lynn, Jian Hui Low, Yee Siang Lim, Chwee Tat Koe, Tiffany Woo, Junyu Zhao, Ganakirthan Kalpenath Rajah, Wee Jug Teow, Royston Kwok, Cheng Peow Bobby Tan, Lai Ping Yaw, Torsten Wuestefeld, Mei Chin Lee, Huck Hui Ng
Journal: Journal of Hepatology (2024)
SAT-209-YI A Markov model unveiling the impact of Resmetirom on the natural history of MASLD patients with baseline significant or severe liver fibrosis
Authors: Grazia Pennisi, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Carlo Ciccioli, Ciro Celsa, Giuseppe Infantino, Adele Tulone, Vito Di Marco, Calogero Camma, Salvatore Petta
Journal: Journal of Hepatology (2024)
TOP-400 Impact of bulevirtide given with or without nucleos (t)ide analogues on 48-week virologic outcomes in patients with chronic hepatitis delta virus infection
Authors: Pietro Lampertico, Maurizia Brunetto, Maria Buti, Soo Aleman, Pavel Bogomolov, Vladimir Chulanov, Nina Mamonova, Viacheslav Morozov, Olga Sagalova, Tatyana Stepanova, John F. Flaherty, Mingyang Li, Dmitry Manuilov, Ben L. Da, Renee-Claude Mercier, Grace M. Chee, Markus Cornberg, Heiner Wedemeyer, Tarik Asselah
Journal: Journal of Hepatology (2024)
FRI-379 Feasibility of aMAP combined with liver stiffness assessed using transient elastography for prediction of hepatocellular carcinoma development in patients with chronic hepatitis B
Authors: Hye Yeon Chon, Hyung Joon Yim, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
Journal: Journal of Hepatology (2024)
THU-419 Regression of hepatic fibrosis in patients with chronic hepatitis C treated with direct-acting antivirals (DAAs). A long-term, prospective, observational study
Authors: Evdoxia Avramopoulou, Efthymios Tsounis, Stavros Kanaloupitis, Konstanitnos Zisimopoulos, Maria Kalafateli, Ioanna Aggeletopoulou, Christos Sotiropoulos, Theodora Kafentzi, Georgios Geramoutsos, Odysseas Ampazis, Georgia Diamantopoulou, Angeliki Tsintoni, Konstantinos Thomopoulos, Christos Triantos
Journal: Journal of Hepatology (2024)
THU-215 Artificial intelligence-derived granular histological markers of fibrosis from hematoxylin and eosin-stained whole slide images associate with non-invasive tests of fibrosis and prognosis to cirrhosis in patients with metabolic dysfunction-associated steatohepatitis
Authors: Neel Patel, Lara Murray, Adam Stanford-Moore, Victoria Mountain, Jun Xu, Lisa Boyette, Benjamin Glass, Timothy R. Watkins, Andrew N. Billin, Ylaine Gerardin, Robert Egger
Journal: Journal of Hepatology (2024)
THU-366 Use of proton pump inhibitors among German Hepatitis C patients treated with sofosbuvir/velpatasvir: Data from the German Hepatitis C-Registry (2016–2022)
Authors: Markus Cornberg, Gerlinde Teuber, Ralf Link, Uwe Naumann, Hartwig Klinker, Christine John, Candido Hernández, Marianna Schwenken, Christoph Sarrazin
Journal: Journal of Hepatology (2024)
THU-209 Effect of inhibition of the protein tyrosine phosphatase 1B in liver progenitor cells under an steatohepatitis environment in mice
Authors: Pilar Valdecantos, Silvia Calero Pérez, Alma Astudillo, Jesús Balsinde, David Sebastian, Laura Herrero, Angela Martinez Valverde
Journal: Journal of Hepatology (2024)
THU-362 Ravidasvir in combination with sofosbuvir for 12 or 24 weeks achieved high sustained virological response rates in genotype 3 chronic hepatitis C without or with compensated liver cirrhosis
Authors: Soek Siam Tan, Caroline Menétrey, Isabela Ribeiro, Nicolas Salvadori, Sabine Yerly, Nicole Ngo-Giang-Huong, Graciela Diap
Journal: Journal of Hepatology (2024)
TOP-204 Inhibition of sodium-glucose cotransporter-2 and liver-related complications in diabetic patients
Authors: SungWon Chung, Hyunjae Shin, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Jung-Hwan Yoon, Jeong-Hoon Lee, Yoon Jun Kim
Journal: Journal of Hepatology (2024)
WED-336 RESIST-NASH: a regional network for identification and referral of masld patients at risk for liver fibrosis
Authors: Grazia Pennisi, Silvio Buscemi, Gaetano Bertino, Lucia Frittitta, Francesco Purrello, Giovanni Raimondo, Fabio Cartabellotta, Maurizio Russello, Giuseppe Malizia, Antonio Carroccio, Antonino Tuttolomondo, Salvatore Camilleri, Giovanni Magrì, Anna Licata, Angelo Baldassare Cefalù, Marco Distefano, Carla Giordano, Chiara Iaria, Ignazio Scalisi, Prestileo Tullio, Maria Luisa Arpi, Vito Di Marco, Calogero Camma, Salvatore Petta
Journal: Journal of Hepatology (2024)
WED-485 Uptake in viral hepatitis screening, vaccination and linkage to care among at-risk migrants in Catalonia, Spain: three years of a community-based intervention
Authors: Camila Picchio, Aina Nicolàs Olivé, Daniel K Nomah, Ariadna Rando-Segura, Maria Buti, Sabela Lens, Xavier Forns, Mireia Miquel, Sergio Rodriguez-Tajes, Francisco Javier Pamplona Portero, Carmen López Núñez, Francisco Rodríguez-Frías, Jeffrey V Lazarus
Journal: Journal of Hepatology (2024)
THU-383 Predictive performance of HCC risk scores in chronic hepatitis C patients with advanced fibrosis after achieving SVR: real-world experience from a tertiary UK centre
Authors: Riham Soliman, Saima Ajaz, James Lok, Mercy Karoney, Evangelos Chalatsis, Ivana Carey, Mary D Cannon, Kathryn Oakes, Teresa Bowyer, Kosh Agarwal, Maria Guerra Veloz
Journal: Journal of Hepatology (2024)
FRI-390 Off-treatment outcomes after discontinuing tenofovir-based treatment in hepatitis B e antigen-positive and hepatitis B e antigen-negative patients with chronic hepatitis B virus
Authors: Maria Buti, Henry L.Y. Chan, Scott K. Fung, Cheng-Yuan Peng, Frida Abramov, Dana Tedesco, Hongyuan Wang, Leland J. Yee, John F. Flaherty, Edward J. Gane, Young-Suk Lim, Harry L.A. Janssen, Kosh Agarwal
Journal: Journal of Hepatology (2024)
FRI-427 Chronic hepatitis delta with normal ALT and hepatitis D viremia: unravelling its natural history
Authors: Muge Ozari Gulnar, Habiba Kamal, Adriana Palom, Sena Arici, Rafael Esteban, Esra Tunç, Onur Keskin, Ramazan Idilman, Maria Buti, Soo Aleman, Cihan Yurdaydin
Journal: Journal of Hepatology (2024)
TOP-144-YI Heterozygosity for rare Apolipoprotein B variants predispose to severe metabolic associated steatotic liver disease
Authors: Matteo Mureddu, Serena Pelusi, Luisa Ronzoni, Francesco Malvestiti, Vittoria Moretti, Hadi Eigadeh, Giorgio Soardo, Alessandro Federico, Francesco Paolo Russo, Anna Ludovica Fracanzani, Umberto Vespasiani-Gentilucci, Luca Miele, Elisabetta Bugianesi, Roberta D'Ambrosio, Salvatore Petta, Mirella Fraquelli, Daniele Prati, Luca Valenti
Journal: Journal of Hepatology (2024)
THU-290-YI Single nucleotide polymorphism analysis for predicting metabolic-associated fatty liver disease development in patients with severe obesity (types II and III)
Authors: Juan Manuel Jiménez-Aguilar, Andrea Jiménez-Franco, Helena Castañé, Alina-Iuliana Onoiu, Vicente Cambra-Cortes, Cristina Placed-Gallego, Cristian Martínez-Navidad, Jordi Camps, Jorge Joven
Journal: Journal of Hepatology (2024)
WED-446 Safety of direct-acting antivirals for hepatitis C infection and direct oral anticoagulants co-administration: an italian multicentric study
Authors: Valerio Rosato, Marcello Dallio, Angiola Spinetti, Alessia Ciancio, Michele Milella, Piero Colombatto, Giuseppe D'Adamo, Elena Rosselli Del Turco, Paolo Gallo, Nicola Pugliese, Roberta D'Ambrosio, Elisa Colella, Maurizia Brunetto, Andrea Falcomatà, Umberto Vespasiani-Gentilucci, Stella De Nicola, Alessio Aghemo, Pietro Lampertico, Alessandro Soria, Antonio Izzi, Alessandro Federico, Davide Mastrocinque, Ernesto Claar
Journal: Journal of Hepatology (2024)
WED-166 Efficacy and safety of odevixibat in a subgroup of adult patients with progressive familial intrahepatic cholestasis in the PEDFIC 2 study
Authors: Henkjan J. Verkade, Kathleen M. Loomes, Janis M. Stoll, Tao Gu, Anthony Loizides, Christof Maucksch
Journal: Journal of Hepatology (2024)
WED-331-YI Subclinical myocardial fibrosis is related to disease severity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Authors: Puria Nabilou, Signe Wiese, Liv Hetland, Mikkel Werge, Mira Thing, Elias Rashu, Anders Junker, Mads Barløse, Hartwig Siebner, Søren Møller, Flemming Bendtsen, Lise Lotte Gluud, Jens Hove
Journal: Journal of Hepatology (2024)
SAT-342-YI PegIFNα treatment in NUC-suppressed HBV/HDV-infected mice with high numbers of HDV-monoinfected cells reduces HDV infection below the limit of quantification
Authors: Annika Volmari, Tassilo Volz, Lena Allweiss, Marc Luetgehmann, Simon Fletcher, Meghan Holdorf, Robert Muench, Maura Dandri
Journal: Journal of Hepatology (2024)